WallStreetZenWallStreetZen

NASDAQ: BLRX
Biolinerx Ltd Stock Ownership - Who owns Biolinerx?

Insider buying vs selling

Have Biolinerx Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BLRX insiders and whales buy or sell their stock.

BLRX Shareholders

What type of owners hold Biolinerx Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Morgan Stanley0.02%238,261$156.30kInstitution
Susquehanna International Group LLP0.01%129,994$85.28kInstitution
Atria Wealth Solutions Inc0.01%110,366$72.40kInstitution
Lpl Financial LLC0.01%100,323$65.81kInstitution
Pvg Asset Management Corp0.01%61,840$40.57kInstitution
Values First Advisors Inc0.00%52,168$34.22kInstitution
Envestnet Asset Management Inc0.00%46,647$30.60kInstitution
Geneos Wealth Management Inc0.00%40,500$26.57kInstitution
Qube Research Technologies Ltd0.00%40,435$26.53kInstitution
Geode Capital Management LLC0.00%39,993$26.24kInstitution

1 of 3

BLRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BLRX0.10%0.00%
JAGX0.45%3.48%
ABIO4.98%95.02%
CALC2.26%97.74%Net BuyingNet Buying
ELDN23.14%76.86%

Biolinerx Stock Ownership FAQ

Who owns Biolinerx?

Biolinerx (NASDAQ: BLRX) is owned by 0.10% institutional shareholders, 0.00% Biolinerx insiders, and 99.90% retail investors. Morgan Stanley is the largest individual Biolinerx shareholder, owning 238,261.00 shares representing 0.02% of the company. Morgan Stanley's Biolinerx shares are currently valued at $161.30k.

If you're new to stock investing, here's how to buy Biolinerx stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.